Clinical Trial Update: Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive Patients [Phase 4]

View source ↗

Summary

A Phase 4 study comparing the antihypertensive effects and neurohormonal marker changes of fimasartan and atenolol in patients with essential hypertension under…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Atenolol (Atenolol)
• Fimasartan (fimasartan)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Hypertension | Phase 4 | Status: COMPLETED